Showing results (651-660 of 2,706) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|June 22, 2023
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infectionNoé Brasier, H Ceren Ates, Juliane R Sempionatto, et al.
The Lancet. Infectious Diseases|February 24, 2007
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysisBenjamin M P Tang, Guy D Eslick, Jonathan C Craig, et al.
The Lancet. Infectious Diseases|July 29, 2026
Impact of directly observed treatment and extended age range of seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso: a three-group, open-label, cluster-randomised, controlled trialJean Baptiste Yaro, Alphonse Ouedraogo, Marta Moreno, et al.
The Lancet. Infectious Diseases|June 18, 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational studyJameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, et al.
The Lancet. Infectious Diseases|December 23, 2023
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trialYoshiaki Oda, Yuji Kumagai, Manabu Kanai, et al.
The Lancet. Infectious Diseases|July 8, 2026
Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial
The Lancet. Infectious Diseases|March 26, 2026
Methodological quality assessment tool for observational studies comparing treatment effectiveness in infectious diseases: a Delphi consensus and application to studies on bloodstream infections due to carbapenem-resistant EnterobacteralesGiulia Zumbo, Martina Beltrami, Jose M Bravo-Ferrer, et al.
The Lancet. Infectious Diseases|March 28, 2026
Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort studyMorgan K Walker, Christina Yek, Sadia Sarzynski, et al.
The Lancet. Infectious Diseases|April 24, 2026
The impact of clinical metagenomic testing on patient management: facts versus fantasyJulianne R Brown, Charles Y Chiu, F Xavier López-Labrador, et al.
The Lancet. Infectious Diseases|August 19, 2026
Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trialRocio Cardenas, Axel Kroeger, Max Petzold, et al.
Pageof 271